Vimarsana
Biggest News Aggregation in the World

Page 4 - Tim Dyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Dyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Dyer Today - Breaking & Trending Today

Addex Announces Participation in the Bio-Europe 2023 Conference - Vimarsana News

Addex Announces Participation in the Bio-Europe 2023 Conference

Geneva, Switzerland, November 2, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Tim...

Q-Tip Joins The Team Behind Broadway Musical About Muhammad Ali - Vimarsana News

Q-Tip Joins The Team Behind Broadway Musical About Muhammad Ali

Q-Tip has extended his musical talents to the Great White Way, revealing that he's joined the Broadway team behind the Muhammad Ali musical.

F-35 pilot describes reason for nighttime training - Vimarsana News

F-35 pilot describes reason for nighttime training

MADISON, Wis. -- Madison's east side might be a bit noisy through the next two weeks. Wisconsin's 115th Fighter Wing, based at Truax Field, is running a series of nighttime

Addex Announces Plan to Implement ADS Ratio Change - Vimarsana News

Addex Announces Plan to Implement ADS Ratio Change

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 6, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”) from the current ADS Ratio of one (1) ADS to six (6) ordinary shares to a new ADS Ratio of one (1) ADS to one hundred and twenty (

Source: yahoo.com
Addex Therapeutics focused on securing new partnerships to fund promising treatments - Vimarsana News

Addex Therapeutics focused on securing new partnerships to fund promising treatments

Addex Therapeutics Ltd (NASDAQ:ADXN, SGX:ADXN) co-founder and CEO Tim Dyer speaks to Thomas Warner from Proactive about the work that the central nervous...